Putnam RetirementReady 2065 Class Y (PCJSX) Quote

So if Teoxane gets to roll their shares into the new entity, why the other minor shareholders dont have such option?

Because Crown gets to choose who it wants to join in the buying group, and typically that is restricted to important members of management and investors with some strat

No parlay, 2 different lineups in same contest, or same lineup in 2 different contests. Reduce volatility,.

https://techcrunch.com/2024/05/13/gvs-youngest-partner-has-launched-her-own-firm/?utm_source=startupclub.tv&utm_medium=newsletter&utm_campaign=StartupClubNewsletter

GV’s youngest partner has launched her own firm

Terri Burns, a former partner at GV, is venturing into a

Posted5. First, we have to have enough buy share volume for the sell short trades. Second, we SET SELL HIGH our shares. That's our right. Third, the short sellers will come up with fade shares to cover the share price back down. Four, we buy close to the end of day is best. That way, the short selle

$IGPK to .0095!

Remember the FBI says its not a matter of if but when a terroist group allowed inside the USA will strike

care to provide some proof of what the FBI supposedly said or should we trust the actual assessment that says American citizens are more likely to develop into a concern than ov

https://thenextweb.com/news/einride-starts-building-worlds-largest-autonomous-trucking-network-in-dubai?utm_source=startupclub.tv&utm_medium=newsletter&utm_campaign=StartupClubNewsletter

That only time will tell . NW hasn’t event started preparing FDA application as far as we know .

OPEN AI --- https://www.linkedin.com/pulse/senates-32b-ai-gamble-pay-off-caya-jose-cayasso--6mj2e/

https://www.entrepreneur.com/business-news/openai-chief-scientist-cofounder-ilya-sutskever-resigns/474211?utm_source=startupclub.tv&utm_medium=newsletter&utm_campaign=StartupClubNewslett

Posting the numbers now will track the ad exposure results, when they start. Good posting by my take.

"Invest 15k with Jake P Noch and it will be worth $20 bucks, invest with Jake and success will elude you." "Defrauding others doesn't make you successful, it makes you a D bag. You can have all the money in the world yet still be considered a failure."
-Walter-

Lol
Here comes the height of being illogical . Did you even read the study posted .
No wonder your bosses are not doing well with employees like you .

Yes, it did:

According to the Amphera website ("pipline" page), the completed phase II pancreatic REACTIVE phase II trial was described as https://www.amphera.nl/pipeline/ "an open label phase II study" . I also confirmed that Amphere is https://www.amphera.nl/mesopher-cell-thera

Gary Gensler is a criminal WOOHOOOOOO XRP🥳🖕

>>Dr Linda Liau, chair of neurosurgery, UCLA Health, commented: “This clinical trial represents a novel and potentially transformative approach to treating high-grade gliomas in children and young adults.

https://pmlive.com/pharma_news/ucla-launches-study-of-personalised-cancer-vaccin

Pretty safe to say they are sending a message to everyone......

This guy gets it.

$SINC is gonna fly

$AGBA Chart is on a solid uptrend heading into next week. The PSAR flipped bullish last week. The RSI had a bullish cross and the MACD also had a bullish cross last week! Large move brewing here!

https://investorshub.advfn.com/uimage/uploads/2024/9/28/cntehagba.png

$AGBA Chart is on a solid uptrend heading into next week. The PSAR flipped bullish last week. The RSI had a bullish cross and the MACD also had a bullish cross last week! Large move brewing here!

https://investorshub.advfn.com/uimage/uploads/2024/9/28/cntehagba.png

I’ve got a dog. If it gets cancer 15 years from now, hopefully, Mesopher will an option.

A Notice to the Board; The I-ON Digital Corp Security Details was updated, . . .
again today, - at OTC Markets - Saturday, September 28, 2024 !!!
Note; ( No change on the OS, but - Plans for a - RS . . .
was announced on September 20, 2024 !!! )

~ Note - The Compa

You are correct. The Copilot AI quote I posted was incorrect. The accurate info is included in my response to your correction:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175155297

I got you $weet$$$

Still growing- Good places to live outside of the city. Of course, TRAFFIC is terrible. Still a SAFE place to live!

If that’s the only play for Germany, and if German gov. Funds the study, then I finally agree with your new trial mandate you’ve been pushing. However, not because VAZKEPA needs validation but because it’s now German law.